Weight Loss Medication News

This living topic explores the growing influence of weight loss medications, particularly GLP-1 receptor agonists, on obesity treatment and healthcare access. Key issues include the effectiveness of these drugs, the rising demand for both injectable and oral options, and the financial burden associated with monthly treatment costs, which can exceed $1,000. Articles examine the disparities in access to these medications, regional trends in usage, and the challenges posed by insurance coverage limitations. The topic also delves into concerns surrounding side effects, long-term efficacy, and the evolving landscape of prescription weight loss treatments.

Latest

GLP-1 drugs may work in a surprising way, new study finds

New research challenges what scientists thought they knew about how these popular medications support weight loss

Sep. 16, 2026 By Kristen Dalli

Yale researchers found that certain hunger-related brain cells may actually help GLP-1 drugs sustain weight loss.

The study used female mice and combined several methods to examine how the brain responded to semaglutide.

The findings could help researchers better understand GLP-1 medications, but more research is needed to determine whether the same process occurs in people.

GLP-1 medications such as semaglutide have become widely known for helping people lose weight. But s...

Read Article

2026